Skip to main content
Lotus Pharm logo

Lotus Pharm — Investor Relations & Filings

Ticker · 1795 ISIN · TW0001795003 LEI · 984500BEECDBC04KP716 TW Manufacturing
Filings indexed 2,732 across all filing types
Latest filing 2022-06-14 Investor Presentation
Country TW Taiwan
Listing TW 1795

About Lotus Pharm

http://www.lotuspharm.com.tw

Lotus Pharmaceutical Co., Ltd. is a global specialty organization focused on the development, manufacturing, and commercialization of high-barrier generic and specialty medicines. The company specializes in complex generics, with a primary focus on oncology, immunology, and addiction treatment. Its portfolio includes technically demanding products such as Lenalidomide, Suboxone, Nintedanib, and Vinorelbine, as well as an advancing pipeline of biosimilars and 505(b)(2) oncology candidates. Utilizing an integrated R&D and manufacturing platform, the company executes a "2x2" growth strategy centered on dual market expansion and product diversification. Its commercial footprint spans over 90 markets globally, maintaining a strong presence in the Asia-Pacific region and the United States. The company prioritizes high technical entry barriers and cost-effective therapeutic solutions to improve global patient access to essential medications.

Recent filings

Filing Released Lang Actions
111年06月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a listing from a public information observation station showing details about a scheduled investor presentation (法人說明會) including date, time, location, and links to presentation materials. It specifically mentions a corporate day event where the company will explain financial and operational status to investors. The content is consistent with an Investor Presentation (IP) rather than a full report or announcement of voting results, dividends, or regulatory filings. The document length is short and it contains presentation details, not a full financial report or earnings release.
2022-06-14 Chinese
澄清經濟日報111/06/12報導
Regulatory Filings Classification · 95% confidence The document is a short announcement clarifying a media report about the company's financial performance. It explicitly states that the company has not prepared financial forecasts and that actual financial results are available on the public information observatory. The document is a factual clarification and does not contain any financial statements, detailed financial data, or report content. It is also very short (715 characters) and serves as a public clarification notice rather than a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-06-13 Chinese
111年5月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 美時, providing information on fund loans and endorsement guarantees for the current and previous months. It contains tabular data on financial limits and balances but is very short (619 characters) and does not include comprehensive financial statements or detailed analysis. It appears to be a regulatory disclosure or compliance update rather than a full financial report or announcement of a meeting or voting results. There is no indication of an annual or interim report, audit report, earnings release, or other specific filings. Given the short length and nature of the content, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other categories.
2022-06-10 Chinese
111年5月營業收入
Regulatory Filings Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 美時, with data for May 2022 (民國111年05月). It includes percentage changes compared to the previous year and explanatory notes about accounting standards and reporting practices. The document is very short (780 characters) and primarily presents financial summary data without detailed financial statements or management discussion. It does not appear to be a full financial report like an Annual Report (10-K) or Interim Report (IR). It also does not fit categories like Earnings Release (ER) because it lacks key highlights or narrative. The document is more of a regulatory or public disclosure summary of financial data. Given the short length and nature, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2022-06-10 Chinese
代子公司Lotus International Pte. Ltd依「公開發行公司資金 貸與及背書保證處理準則」第二十五條第一項第二、三、四款之 規定公告
Regulatory Filings Classification · 95% confidence The document is a regulatory announcement from a listed company (1795 美時) regarding a guarantee provided by its subsidiary Lotus International Pte. Ltd. It details the amount of guarantee, the relationship between the companies, financial figures related to the guarantee, and other related information. The document is short (1193 characters) and is a specific disclosure about a financial guarantee, not a full financial report or management discussion. It does not contain comprehensive financial statements or detailed analysis. It is a regulatory filing disclosing a specific event related to financial guarantees as required by regulations. Therefore, it fits best under Regulatory Filings (RNS).
2022-06-09 Chinese
111年6月2日內部人設質解質
Director's Dealing Classification · 95% confidence The document is a tabular report showing changes in pledged shares (質設股數) for a company, including details about the pledgor, pledgee, and dates. It is a notification of a director's or major shareholder's dealing with shares, specifically about share pledging activity. The document length is short and contains specific share transaction data by a director or related party. This fits the definition of Director's Dealing (DIRS).
2022-06-06 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.